https://www.avient.com/sites/default/files/2020-07/case-study-one-pager-versaflex-vacuum-cleaner-wheel.pdf
All Rights Reserved.
All Rights Reserved. https://www.polyone.com/products/thermoplastic-elastomers/versaflex-thermoplastic-elastomers Vacuum cleaner manufacturer
https://www.avient.com/sites/default/files/2022-06/Maxxam FR Injection Molding Processing Guide.pdf
Additional draft may be required for grained/textured surfaces Gates • All types of gates can be used such as pin, fan, tunnel, tab and edge gates.
Tool Steel • P20 tool steel is acceptable when proper processing and shut down procedures are followed • Chrome plating or PH stainless steel is preferred for all halogen-based systems • The use of stainless steel in hot runner systems is highly suggested • Avoid the use of aluminum when designing production tools Vents • Place vents at the end of fill and anywhere potential knit/weld lines will occur • All vents need to be vented to atmosphere • Cut vent depths to 0.0010"–0.0015" with a minimum 0.040" land length.
You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.
https://www.avient.com/sites/default/files/2024-10/Compensation Committee Charter - Final.pdf
• Make recommendations to the Board with respect to the approval of incentive compensation plans for executive officers and all equity-based plans. • For annual (or other short term) incentive plans: o Review and approve annual incentive plans (including performance criteria, target awards, payout criteria and similar award design items applicable under such plans) that are applicable to executive officers and any Company officers reporting directly to the Chief Executive Officer. o Review and approve attainment levels and payments to executive officers and any other Company officers reporting directly to the Chief Executive Officer. • For long-term and equity-based incentive plans: o Review and approve the performance criteria, target awards, payout criteria and similar award design items for recipients of grants and awards under the plans. o Review and approve grants, awards, and attainment levels, including equity-based grants, to recipients of grants and awards under such plans. o Review and approve payments for performance-based grants and awards to executive officers and any other Company officers reporting directly to the Chief Executive Officer, as applicable, under such plans. • Administer the Company’s equity-based incentive compensation plans and other plans adopted by the Board that contemplate administration by the Committee. • Review and approve the terms of all employment agreements, executive severance plan and agreements, management continuity agreements and change in control agreements for elected officers. • Approve the adoption and amendment of Company stock ownership guidelines and annually review compliance with these guidelines. 3 Non-employee Director Compensation. • Review the compensation of non-employee directors and make recommendations to the Board regarding changes to existing compensation levels. • Review and recommend to the Board for its approval equity-based grants and awards to non- employee directors under the Company’s equity-based plans and annually review compliance with Company stock ownership guidelines.
Independence Assessment of Outside Advisers • The Committee may select a compensation consultant, legal counsel or other adviser to the Committee or receive advice from a compensation consultant, legal counsel, or other adviser only after taking into consideration all factors relevant to that person’s independence from management, including the following: o the provision of other services to the Company by the employer of the compensation consultant, legal counsel or other adviser; o the amount of fees received from the Company by the employer of the compensation consultant, legal counsel, or other adviser, as a percentage of the total revenue of the employer of the compensation consultant, legal counsel or other adviser; o the policies and procedures of the employer of the compensation consultant, legal counsel or other adviser that are designed to prevent conflicts of interest; o any business or personal relationship of the compensation consultant, legal counsel, or other adviser with a member of the Committee; o any stock of the Company owned by the compensation consultant, legal counsel, or other adviser; and o any business or personal relationship of the compensation consultant, legal counsel, other adviser, or the employer of the adviser with an executive officer of the Company. • The Committee is not required to assess the independence of any in-house legal counsel or compensation consultant, legal counsel, or other adviser whose role is limited to the 5 following activities for which no disclosure would be required under Item 407(e)(3)(iii) of Regulation S-K: consulting on any broad-based plan that does not discriminate in scope, terms, or operation, in favor of executive officers or non-employee directors of the Company, and that is available generally to all salaried employees; or providing information that either is not customized for a particular company or that is customized based on parameters that are not developed by the compensation consultant, and about which the compensation consultant does not provide advice. • The Committee shall evaluate whether any compensation consultant retained or to be retained by it has any conflict of interest in accordance with Item 407(e)(3)(iv) of Regulation S-K.
However, the Committee shall meet regularly without such members present, and in all cases the Chief Executive Officer and any other such officers shall not be present at those portions of meetings at which their individual compensation or performance is discussed or determined. • The Committee may appoint subcommittees from time to time as needed, each of which will have the specific duties and responsibilities delegated to it by the Committee. • The Committee may delegate its authority under this Charter relating to employees other than executive officers and non-employee directors, to the extent it deems appropriate and consistent with law and customary practice and may otherwise fully delegate authority relating to matters it deems to be ministerial. • The Committee may delegate its authority under this Charter relating to employee benefit plans in which executive officers participate if such employee benefit plans are broad-based, to the extent it deems appropriate and consistent with law and customary practice. • The Corporate Secretary or designee will be responsible for keeping minutes of the Committee meetings. • The Committee will meet at least four times a year and at such other times as may be requested by the Committee Chair. • The Committee will annually review its charter and recommend any changes to the Governance and Corporate Responsibility Committee.
https://www.avient.com/sites/default/files/2020-08/trilliant-case-study-1.pdf
MANUFACTURER BOOSTS DISINFECTANT RESISTANCE FOR MEDICAL DEVICE HOUSINGS HIGH PERFORMANCE MEDICAL FORMULATIONS © 2020, All Rights Reserved Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012 To learn more about Trilliant HC, contact Avient at +1.844.4AVIENT (1.844.428.4368).
After fully understanding all of the requirements, Avient’s technology team began to formulate an easy- to-mold, durable and aesthetically pleasing specialty polymer that provided processing flexibility and wouldn’t require retooling.
The results showed the Avient material outperformed typical FR PC/ABS and had an added bonus: a UL yellow card V0 flammability rating for all colors and some thicknesses.* Avient also used its custom color matching capabilities to provide pre-colored material that simplified molding, while the material’s wide processing window helped accommodate a variety of molding environments. * V0 @ 1.5 and 3.0mm FR PC/ABS failed 0% 20% 40% 60% 80% 100% 120% 140% Virex TB Clorox Broad Spectrum CaviCide SaniCloth Plus wipes 1% strain not tested 1% strain not tested FR PC/ABS failed FR PC/ABS failed FR PC/ABS failed FR PC / ABS (1.0% Strain) FR PC / ABS (1.5% Strain) Trilliant HC (1.0% strain) Trilliant HC (1.5% strain) FR PC/ABS failed 0% 20% 40% 60% 80% 100% 120% 140% Virex TB Clorox Broad Spectrum CaviCide SaniCloth Plus wipes 1% strain not tested 1% strain not tested FR PC/ABS failed FR PC/ABS failed FR PC/ABS failed FR PC / ABS (1.0% Strain) FR PC / ABS (1.5% Strain) Trilliant HC (1.0% strain) Trilliant HC (1.5% strain) TENSILE STRENGTH RETENTION AFTER 7 DAYS EXPOSURE Both materials were tested according to ASTM D543 for 7 days.
https://www.avient.com/sites/default/files/resources/Terms_and_Conditions_regarding_Resale_of_PolyOne_Products.pdf
Buyer assumes all risk and liability for the resale of the Product, including the Product’s selection, use and performance, and Buyer will indemnify and hold harmless PolyOne from and against any and all liabilities, damages, losses, claims, suits or judgments, and expenses (including reasonable attorney fees) that PolyOne may incur to the extent caused by Buyer’s actions. 3.
Buyer shall comply with all applicable laws, regulations and administrative requirements, including those respecting unfair trade practices, anti-bribery, anti-corruption, anti-competitive or restrictive practices, health, safety, environmental, export controls, and trade sanctions.
https://www.avient.com/sites/default/files/2023-01/Mevopur Healthcare Functional Additives Chemical Foaming Agents Application Bulletin.pdf
You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.
It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including the suitability of all raw materials and components used for its manufacture.
https://www.avient.com/sites/default/files/2023-03/Mevopur Healthcare Functional Additives Antistatic Application Bulletin_0.pdf
You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.
It is the responsibility of the medical device manufacturer and the person placing the medical device on the market to ensure compliance of the medical device with all applicable laws and regulations, including the suitability of all raw materials and components used for its manufacture.
https://www.avient.com/sites/default/files/2022-09/Additives and Colorants for Stadium and Arena Seats Application Bulletin.pdf
All our solutions for stadium and arena seats are compliant under REACH and RoHS.
UV STABILIZER/COLOR COMBINATIONS • Combines color and UV stabilization for use in PP and PA • Ingredients screened with accelerated weather testing* • Excellent weather resistance properties (against chalking, embrittlement) • Long-term colorfastness and light stability UV STABILIZER/FLAME RETARDANT/ COLOR COMBINATIONS • Combines low halogen flame retardants, UV stabilizers and color for use in PP and PA • Ingredients screened with accelerated weather testing* • Excellent weather resistance properties (against chalking, embrittlement) • Compliant with local fire standards (e.g.: AFNOR M 2 in France, DIN 4102 B 2–B 1 in Germany, UNI 8457–9174 C 1 in Italy, BKZ 5.2 in Switzerland, BS 5852.1990 CRIB 3–5 in UK)** • Standard portfolio available for PP injection molded applications APPLICATION BULLETIN * Laboratory weathering testing may not be determinative of all conditions of use; the end user must determine suitability of a product for its intended use ** Contact us for more information on regulatory compliance Copyright © 2022, Avient Corporation.
You have the responsibility to conduct full-scale end-product performance testing to determine suitability in your application, and you assume all risk and liability arising from your use of the information and/or use or handling of any product.
https://www.avient.com/sites/default/files/2020-09/swiss-army-knife-case-study.pdf
MATERIAL COMBO AMPLIFIES COMFORT AND USABILITY FOR SWISS ARMY™ KNIFE VICTORINOX™ UPDATES ITS ICONIC POCKET KNIFE WITH MATERIALS THAT MAKE A DIFFERENCE © 2020, All Rights Reserved Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012 THE CHALLENGE The Original Swiss Army™ knife from Victorinox™ is one of the world’s most recognizable brands, and the company has earned a strong reputation for the quality of its pocket knives.
Today, the tradition of quality and innovation lives on, and the Swiss Army knife has become a trusted companion of consumers, adventurers, military and rescue personnel all over the world.
It all began when the Swiss Army asked Victorinox to update the military-issue Swiss Soldier’s™ Knife.
https://www.avient.com/sites/default/files/2023-03/Therma-Tech Heat Sink for Auto Lights Case Study.pdf
THERMALLY CONDUCTIVE THERMOPLASTICS REDUCE WEIGHT IN VEHICLE LIGHT HEAT SINKS THERMALLY CONDUCTIVE THERMOPLASTICS REDUCE WEIGHT AND DISSIPATE HEAT © 2023, All Rights Reserved Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012 Interested in learning more about thermally conductive thermoplastics?
By replacing aluminum with a thermoplastic, Elausa was looking to reduce cost, part weight and improve ease of manufacturing, all while maintaining an equivalent level of thermal conductivity and ensuring comparable performance.
An award-winning group of highly experienced industrial designers, design engineers and prototyping technicians, Avient Design helps customers with all aspects of new product development, from concept to production.